- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neuroscientific Biopharmaceuticals Ltd (NSB)
Neuroscientific Biopharmaceuticals Ltd stock price live, this page displays ASX NSB stock exchange data. View the NSB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neuroscientific Biopharmaceuticals Ltd real time stock price chart below.
What Is the Neuroscientific Biopharmaceuticals Ltd Stock Price Today?
The Neuroscientific Biopharmaceuticals Ltd stock price today is 0.175.
What Is the Stock Symbol for Neuroscientific Biopharmaceuticals Ltd?
The stock symbol for Neuroscientific Biopharmaceuticals Ltd is ""NSB.""
What Stock Exchange Does Neuroscientific Biopharmaceuticals Ltd Trade On?
Neuroscientific Biopharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Neuroscientific Biopharmaceuticals Ltd a Good Stock to Buy?
Determining whether Neuroscientific Biopharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSB quote. (ISIN: AU0000012973)
What Is the Neuroscientific Biopharmaceuticals Ltd Stock Price Today?
The Neuroscientific Biopharmaceuticals Ltd stock price today is 0.175.
What Is the Stock Symbol for Neuroscientific Biopharmaceuticals Ltd?
The stock symbol for Neuroscientific Biopharmaceuticals Ltd is ""NSB.""
What Stock Exchange Does Neuroscientific Biopharmaceuticals Ltd Trade On?
Neuroscientific Biopharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Neuroscientific Biopharmaceuticals Ltd a Good Stock to Buy?
Determining whether Neuroscientific Biopharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSB quote. (ISIN: AU0000012973)
Sydney
Currency in AUD
0.175
+0.015(+9.38%)
Closed·
Fair Value
An estimate of a Neuroscientific Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.155
0.175
52 wk Range
0.033
0.260
NSB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NSB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Neuroscientific Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1550.175
52 wk Range
0.0330.260
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NSB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Neuroscientific Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has fared poorly over the last month
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Neuroscientific Biopharmaceuticals Ltd Company Profile
NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products. The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer’s disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases. The company was incorporated in 2002 and is based in Perth, Australia.
Compare NSB to Peers and Sector
Metrics to compare | NSB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNSBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −31.5x | −4.1x | −0.6x | |
PEG Ratio | 0.05 | −0.12 | 0.00 | |
Price/Book | 3.5x | 2.4x | 2.6x | |
Price / LTM Sales | 350.4x | 9.8x | 3.3x | |
Upside (Analyst Target) | - | 317.0% | 39.1% | |
Fair Value Upside | Unlock | 12.2% | 5.4% | Unlock |
Earnings
Latest Release
Feb 26, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Neuroscientific Biopharma Trade On?
Neuroscientific Biopharma is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Neuroscientific Biopharma?
The stock symbol for Neuroscientific Biopharma is "NSB."
What Is the Neuroscientific Biopharma Market Cap?
As of today, Neuroscientific Biopharma market cap is 58.20M.
What Is Neuroscientific Biopharma's Earnings Per Share (TTM)?
The Neuroscientific Biopharma EPS (TTM) is 0.01.
From a Technical Analysis Perspective, Is NSB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Neuroscientific Biopharma Stock Split?
Neuroscientific Biopharma has split 0 times.
How Many Employees Does Neuroscientific Biopharma Have?
Neuroscientific Biopharma has 0 employees.
What is the current trading status of Neuroscientific Biopharma (NSB)?
As of 29 Aug 2025, Neuroscientific Biopharma (NSB) is trading at a price of 0.175, with a previous close of 0.16. The stock has fluctuated within a day range of 0.155 to 0.175, while its 52-week range spans from 0.033 to 0.260.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.